Accession Number:

AD1094794

Title:

Enhancing Immune Checkpoint Inhibitor therapy in Kidney Cancer

Descriptive Note:

Technical Report,30 Sep 2018,30 Sep 2019

Corporate Author:

UT Southwestern Medical Center Dallas United States

Personal Author(s):

Report Date:

2019-10-01

Pagination or Media Count:

7.0

Abstract:

The purpose of this work is to develop strategies to enhance immune checkpoint inhibition in kidney cancer. The work is designed to testdifferent strategies to induce or enhance the abscopal in a kidney cancer model by combining ablative techniques or TLR agonists with PD1 inhibitors. Animal Protocol is now ACURO and UTSW approved. Work will start as soon as no cost extension has been approved.

Subject Categories:

  • Medicine and Medical Research
  • Pharmacology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE